If Pfizer's Vaccine Is a Winner, Why Did This Analyst Downgrade Its Stock?

·2-min read
If Pfizer's Vaccine Is a Winner, Why Did This Analyst Downgrade Its Stock?

Mizuho Securities' Vamil Divan expresses concern about the company's post-coronavirus future.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting